Corpuscular autovaccine is a process of creating a vaccine that is based on the use of the body’s own immune cells. This method was developed in 2016 and is already used in many countries around the world to treat various diseases.
An autovaccine is a method of obtaining a vaccine by introducing into the patient’s body the patient’s own immune cells, which have been pre-treated with antigens. This process allows for the creation of a more effective vaccine that will better protect the body from the disease.
One of the main advantages of the autovaccine is that it does not cause allergic reactions, since it does not contain foreign proteins. In addition, the autovaccine can be used to treat any disease, including infectious, oncological and autoimmune.
However, the autovaccine also has disadvantages. For example, it may be less effective than a traditional vaccine because immune cells may not fully respond to disease antigens. In addition, the process of creating an autovaccine may be more complex than creating a traditional vaccine.
Despite these shortcomings, autovaccine is a promising method for treating various diseases and may become one of the main ways to combat infectious diseases in the future.